[HTML][HTML] Progress in the development of new drugs in Alzheimer's disease

A Piau, F Nourhashémi, C Hein, C Caillaud… - The Journal of nutrition …, 2011 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

Progress in the development of new drugs in Alzheimer's disease.

A PIAU, F NOURHASHÉMI, C HEIN… - Journal of Nutrition …, 2011 - search.ebscohost.com
Abstract lzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

Progress in the development of new drugs in Alzheimer's disease

A Piau, F Nourhashémi, C Hein, C Caillaud… - The journal of nutrition …, 2011 - infona.pl
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

Progress in the development of new drugs in Alzheimer's disease.

A Piau, F Nourhashémi, C Hein, C Caillaud, B Vellas - 2011 - cabidigitallibrary.org
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

Progress in the development of new drugs in Alzheimer's disease

A Piau, F Nourhashémi, C Hein, C Caillaud… - The journal of nutrition …, 2011 - Springer
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

Progress in the development of new drugs in Alzheimer's disease

A Piau, F Nourhashémi, C Hein… - The journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

PROGRESS IN THE DEVELOPMENT OF NEW DRUGS IN ALZHEIMER'S DISEASE

A Piau, F Nourhashémi, C Hein… - The Journal of …, 2011 - search.proquest.com
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

Progress in the development of new drugs in Alzheimer's disease.

A Piau, F Nourhashémi, C Hein… - The Journal of …, 2011 - europepmc.org
Alzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …

[引用][C] PROGRESS IN THE DEVELOPMENT OF NEW DRUGS IN ALZHEIMER'S DISEASE

A PIAU, F NOURHASHEMI, C HEIN… - The Journal of …, 2011 - pascal-francis.inist.fr
PROGRESS IN THE DEVELOPMENT OF NEW DRUGS IN ALZHEIMER'S DISEASE CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Progress in the development of new drugs in Alzheimer's disease.

A PIAU, F NOURHASHÉMI, C HEIN… - Journal of Nutrition …, 2011 - search.ebscohost.com
Abstract lzheimer's disease (AD) is an age-related neurodegenerative disease with a global
prevalence estimated at 26.55 million in 2006. During the past decades, several agents …